These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25748050)

  • 21. [Anti-tumor effect of adenovirus-mediated Bcl-XL shRNA in vitro].
    Zhu YP; Li DC; Feng HY; Liu Y; Qian J; Chen YB; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):292-4. PubMed ID: 22454181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5.
    Kim SY; Kim JH; Song JJ
    Cancer Gene Ther; 2013 Feb; 20(2):82-7. PubMed ID: 23306613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis.
    Tolksdorf B; Zarif S; Eberle J; Hazini A; Dieringer B; Jönsson F; Kreppel F; Kurreck J; Fechner H
    J Mol Med (Berl); 2021 Sep; 99(9):1279-1291. PubMed ID: 34028599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
    Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.
    Oh E; Hong J; Kwon OJ; Yun CO
    Sci Rep; 2018 Jan; 8(1):1420. PubMed ID: 29362367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.
    Zhu H; Zhou W; Hu J; Huang Z; Lao W; Huang X; He C
    J Gene Med; 2012 Dec; 14(12):761-8. PubMed ID: 23169477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.
    Zhang R; Zhang X; Ma B; Xiao B; Huang F; Huang P; Ying C; Liu T; Wang Y
    Cancer Gene Ther; 2016 Jun; 23(6):168-77. PubMed ID: 27080225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer.
    Zhu H; Zhu Y; Hu J; Hu W; Liao Y; Zhang J; Wang D; Huang X; Fang B; He C
    Int J Cancer; 2007 Sep; 121(6):1366-72. PubMed ID: 17534896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
    Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.
    Kim SY; Lee DH; Song X; Bartlett DL; Kwon YT; Lee YJ
    Apoptosis; 2014 Nov; 19(11):1603-15. PubMed ID: 25156145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.
    El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C
    Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.
    Wei F; Wang H; Chen X; Li C; Huang Q
    Cancer Biol Ther; 2014 Oct; 15(10):1358-66. PubMed ID: 25019940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.
    Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A
    Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
    Kim DR; Park MY; Lee CS; Shim SH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT
    Cancer Gene Ther; 2011 Jul; 18(7):467-77. PubMed ID: 21455254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
    Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
    Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.